West Tower Group’s Prothena Corp PRTA Stock Holding History

West Tower Group’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-659	Closed	-$45K	–	769
2023 Q2	$45K	Buy	+659	New	+$42.5K	0.03%	226

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

West Tower Group's PRTA Position: Q3 2023 in Review

West Tower Group sold out of Prothena Corp (PRTA) in Q3 2023, closing a stake of 659 shares — an estimated $45K sold.

West Tower Group first reported a position in PRTA in Q2 2023 and held it in 1 quarter. The position peaked at $45K in Q2 2023. 186 funds tracked by Wall St. Rank hold PRTA as of Q3 2023.

West Tower Group reported no remaining Prothena Corp position as of Q3 2023 after selling out during the quarter.
West Tower Group sold 659 Prothena Corp shares in Q3 2023, an estimated $45K.
West Tower Group first reported a position in Prothena Corp in Q2 2023 and held it in 1 quarter.
West Tower Group's Prothena Corp position peaked at $45K in Q2 2023.
186 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2023.

Based on West Tower Group's 13F filing for Q3 2023, filed 14 Nov 2023.